Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD (I. Shakhnoza & D. Qamardinovna, Trans.). (2026). Uzbekistan Open Conference, 1. https://doi.org/10.57033/RSSPMCE-2026-00022